A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
about
Production and clinical development of nanoparticles for gene deliveryPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeuticsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastomaEffective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicineCombination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Cancer stem cell-targeted therapeutics and delivery strategies.Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study.Nanotherapeutics for Gene Modulation that Prevents Apoptosis in the Brain and Fatal Neuroinflammation.Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy.Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor
P2860
Q26752803-5B41F6B1-E81F-4806-8FD3-B8A1D2C7E96FQ26778701-C1072EC5-9CC9-480D-ADCE-805EC4122D6EQ26795601-6893F1E3-770D-4085-8AD0-4376123D32DDQ30366990-55C41A87-F8ED-45E0-B963-0D9DAFF45EA2Q36145632-B272E8E3-F0D9-4F09-B24C-A7705EF4838CQ36403289-948EECBB-22CD-405B-9AEE-9152077A4734Q37694434-5C82E1AD-15CF-412A-8C14-2BC43DED2E53Q38709582-0641BFE1-9CE3-42D4-AAA9-08C516AC8BBBQ38998571-BF40DC0F-49FA-470F-BC63-F91F6DBBFB58Q39014576-D68D1275-EA55-4DFA-9649-B1986F1AA713Q42367187-4A96819A-A940-491B-86AC-FFF491F144E5Q47986500-0524743F-8DE8-4254-B107-D864D96D63A0Q48103351-7A8490BE-C865-4CBE-A57A-49B773A5C0C9Q50499549-8C837AA8-7997-4671-85AF-382C235099D3Q52142503-A962DF19-7EB2-4CEC-8AB6-8A4922EBD936Q55274460-E299D001-A105-429E-8BA2-70D9C0CE8F72Q57137831-19FBAA6E-BDC0-4157-AACD-75B258B79C17
P2860
A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@ast
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@en
type
label
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@ast
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@en
prefLabel
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@ast
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@en
P2093
P2860
P1476
A tumor-targeting p53 nanodeli ...... el of glioblastoma multiforme.
@en
P2093
Antonina Rait
Esther H Chang
Kathleen F Pirollo
Sang-Soo Kim
P2860
P304
P356
10.1016/J.NANO.2014.09.005
P577
2014-09-18T00:00:00Z